FactorPad
Build a Better Process

Stock Risk Measures for Revance Therapeutics Inc

A quantitative factor review, as of September 30, 2020.
  1. Company Info - Description, identity and sector data.
  2. Share Data - Stock earnings and key dates.
  3. Market Risk - Beta, size, liquidity and momentum measures.
  4. Financial Risk - Earnings and dividends.
by Paul Alan Davis, CFA
Updated: October 01, 2020
See how we arrive at an overall risk score of 62 for RVNC below.

/ factorpad.com / stocks / f44xmc.html


An ad-free and cookie-free webpage by FactorPad


RVNC Risk Report

Overview

Our quantitative data points are meant to provide a high-level understanding of factors in equity risk models for Revance Therapeutics Inc. Portfolio managers use these models to forecast risk, optimize portfolios and review performance.

We show how RVNC stock compares to 2,000+ US-based stocks, and to peers in the Health Technology sector and Pharmaceuticals: Other industry.

Please do not consider this data as investment advice. Data is downloaded from sources we deem reliable, but errors may occur.

Company Info

Business Description

Company logo Revance Therapeutics, Inc. is a clinical stage biotechnology company. It engages in the development, manufacturing, and commercialization of novel botulinum toxin products for multiple aesthetic and therapeutic applications. The firm focuses on production of daxibotulinumtoxinA, a botulinum toxin, for aesthetic and therapeutic indications, including facial wrinkles and muscle movement disorders. The company was founded by Jacob M. Waugh and L. Daniel Browne on August 10, 1999 and is headquartered in Newark, CA.

Identity

Sector and Industry

Share Data

Shares and Float

Earnings and Dividends

Market Risk Measures

Many of the following risk metrics are standardized and transformed into quantitative factors in institutional-level risk models.

Rankings below represent percentiles from 1 to 100, with 1 being the lowest rating of risk.

Systematic Risk

Stocks with higher beta exhibit higher sensitivity to the ups and downs in the market. (↑↑)

Company Size

Stocks with higher market capitalization often have lower risk. (↑↓)

Trading Liquidity

Higher average daily dollar volume over the past 30 days implies lower liquidity risk. (↑↓)

Price Momentum

Higher price momentum stocks, aka recent winners, equate to lower risk for many investors. (↑↓)

Financial Risk Measures

Style risk factors often include measures of profitability and payout levels.

Earnings Yield

Companies with higher earnings generally provide lower risk. (↑↓)

Dividend Yield

Companies with higher dividend yields, if sustaintable, are perceived to have lower risk. (↑↓)

/ factorpad.com / stocks / f44xmc.html


RVNC stock risk
REVANCE THERAPEUTICS INC stock beta
RVNC risk report
RVNC f44xmc
RVNC risk analysis
RVNC volatility
REVANCE THERAPEUTICS INC credit risk
RVNC liquidity risk
RVNC leverage
RVNC valuation
RVNC systematic risk
RVNC specific risk
REVANCE THERAPEUTICS INC volatility
RVNC analysis
RVNC financial ratio

This is a new resource, spread the word, tell a friend